Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PKLR | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | HMX3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | ERMAP | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | PRTN3 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | C1orf216 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | CPSF1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | FEZF2 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | CD300LF | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | OR52A5 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | PPM1F | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |